Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Fukumitsu, H. Matsuoka, M. Deguchi, T. Ryoke, Y. Koma, Y. Kasai, D. Masuya, H. Yoshimatsu, Y. Suzuki (Kobe, Japan). Severity of COPD is associated with leg atherosclerosis. Eur Respir J 2010; 36: Suppl. 54, 1304

Member's Comments

No comment yet.

Related content which might interest you: Fatigue in COPD: association with functional status and hospitalisations Source: Eur Respir J 2013; 41: 565-570 Year: 2013 Severity of pulmonary hypertension correlates with patients’ daily physical activity Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 Assessment of severe COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Severity of obstruction in patients with COPD  in a lifecourse approach Source: Virtual Congress 2021 – Health effects of tobacco and medical professionals Year: 2021 Gait Speed as a predictor of mortality in COPD Source: International Congress 2015 – Best abstracts in functional capacity in chronic lung diseases Year: 2015 Comorbidities in COPD patients are not associated to higher disease severity Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation Year: 2011 Osteoporosis, sarcopenia and pulmonary hypertension in relation to GOLD classification vs BODE index in COPD Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Clinical Impact of Gensini score in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Index of myocardial injury CIIS and mortality of patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD management Year: 2011 Associations between muscle wasting and BODE index in chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 The prevalence of quadriceps weakness in COPD and the relationship with disease severity Source: Eur Respir J 2010; 36: 81-88 Year: 2010 Injury of the quadriceps muscle in COPD patients: role of the pulmonary disease and exertion Source: Eur Respir J 2004; 24: Suppl. 48, 217s Year: 2004 Are COPD exacerbations associated with the severity of the disease? Source: Eur Respir J 2005; 26: Suppl. 49, 300s Year: 2005 Severity assessment in acute exacerbations of COPD Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know? Year: 2005 Markers of ageing in the limb muscle of patients with COPD Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Outcome of pulmonary hypertension associated with respiratory disease Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Bronchiectasis  contributes to the severity of COPD Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Severity distribution of physician-diagnosed COPD in the Netherlands Source: Eur Respir J 2003; 22: Suppl. 45, 67s Year: 2003 Comorbidity of atherosclerotic diseases in COPD patients. Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018 Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016